 Kelly Lear-Kaul
Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dosage Forms | 1 | 2012 | 11 | 0.370 |
Why?
| | Asphyxia | 1 | 2012 | 24 | 0.360 |
Why?
| | Deglutition | 1 | 2012 | 73 | 0.350 |
Why?
| | Oxycodone | 1 | 2012 | 52 | 0.350 |
Why?
| | Death, Sudden | 2 | 2016 | 26 | 0.340 |
Why?
| | Airway Obstruction | 1 | 2012 | 153 | 0.320 |
Why?
| | Sodium Hypochlorite | 1 | 2007 | 6 | 0.260 |
Why?
| | Burns, Chemical | 1 | 2007 | 33 | 0.250 |
Why?
| | Herpesvirus 3, Human | 3 | 2015 | 343 | 0.250 |
Why?
| | Disinfectants | 1 | 2007 | 45 | 0.240 |
Why?
| | Temporal Arteries | 2 | 2015 | 45 | 0.220 |
Why?
| | Giant Cell Arteritis | 2 | 2015 | 48 | 0.220 |
Why?
| | Central Nervous System Neoplasms | 2 | 2004 | 177 | 0.210 |
Why?
| | Analgesics, Opioid | 1 | 2012 | 1154 | 0.190 |
Why?
| | Carcinoma, Lobular | 1 | 2003 | 56 | 0.190 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2003 | 90 | 0.190 |
Why?
| | Cause of Death | 1 | 2005 | 472 | 0.180 |
Why?
| | Herpes Zoster | 2 | 2015 | 319 | 0.160 |
Why?
| | Epilepsy | 1 | 2005 | 390 | 0.150 |
Why?
| | Encephalitis, Varicella Zoster | 1 | 2015 | 17 | 0.110 |
Why?
| | Breast Neoplasms | 2 | 2004 | 2393 | 0.100 |
Why?
| | Trigeminal Ganglion | 1 | 2013 | 27 | 0.100 |
Why?
| | Exanthema | 1 | 2013 | 86 | 0.100 |
Why?
| | Forensic Toxicology | 1 | 2012 | 3 | 0.090 |
Why?
| | Forensic Pathology | 1 | 2012 | 9 | 0.090 |
Why?
| | Drug Users | 1 | 2012 | 43 | 0.090 |
Why?
| | Hippocampus | 1 | 2016 | 973 | 0.080 |
Why?
| | Administration, Oral | 1 | 2012 | 867 | 0.070 |
Why?
| | Forensic Medicine | 1 | 2007 | 19 | 0.060 |
Why?
| | Head Injuries, Closed | 1 | 2007 | 49 | 0.060 |
Why?
| | Homicide | 1 | 2007 | 68 | 0.060 |
Why?
| | Models, Animal | 1 | 2007 | 392 | 0.060 |
Why?
| | Middle Aged | 6 | 2015 | 36309 | 0.060 |
Why?
| | Swine | 1 | 2007 | 826 | 0.050 |
Why?
| | Medical Records | 1 | 2005 | 192 | 0.050 |
Why?
| | DNA Probes | 1 | 2003 | 59 | 0.050 |
Why?
| | Genes, erbB-2 | 1 | 2003 | 32 | 0.050 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2003 | 54 | 0.050 |
Why?
| | Gene Amplification | 1 | 2003 | 118 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2004 | 1723 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2003 | 328 | 0.050 |
Why?
| | Concanavalin A | 1 | 2002 | 72 | 0.040 |
Why?
| | Skin | 1 | 2007 | 754 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2004 | 635 | 0.040 |
Why?
| | Adult | 5 | 2013 | 40882 | 0.040 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2002 | 138 | 0.040 |
Why?
| | Leptin | 1 | 2002 | 248 | 0.040 |
Why?
| | Humans | 9 | 2016 | 145785 | 0.040 |
Why?
| | Incidence | 1 | 2005 | 2934 | 0.030 |
Why?
| | Male | 5 | 2015 | 73012 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2003 | 1450 | 0.030 |
Why?
| | Age Factors | 1 | 2005 | 3346 | 0.030 |
Why?
| | Risk Factors | 2 | 2015 | 10919 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2005 | 17330 | 0.030 |
Why?
| | Female | 6 | 2015 | 79045 | 0.030 |
Why?
| | Cerebral Arterial Diseases | 1 | 2015 | 50 | 0.030 |
Why?
| | Colorado | 1 | 2005 | 4556 | 0.030 |
Why?
| | Internationality | 1 | 2015 | 156 | 0.030 |
Why?
| | Death, Sudden, Cardiac | 1 | 2016 | 237 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2013 | 305 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2015 | 8347 | 0.020 |
Why?
| | Biopsy | 1 | 2015 | 1082 | 0.020 |
Why?
| | Comorbidity | 1 | 2015 | 1662 | 0.020 |
Why?
| | Child, Preschool | 1 | 2005 | 11868 | 0.020 |
Why?
| | Obesity | 1 | 2002 | 3118 | 0.020 |
Why?
| | Prevalence | 1 | 2015 | 2875 | 0.020 |
Why?
| | Animals | 2 | 2007 | 38106 | 0.020 |
Why?
| | Adolescent | 1 | 2005 | 22577 | 0.010 |
Why?
| | Aged | 2 | 2015 | 26217 | 0.010 |
Why?
| | Child | 1 | 2005 | 22740 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5925 | 0.010 |
Why?
| | Aurothioglucose | 1 | 2002 | 4 | 0.010 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2004 | 289 | 0.010 |
Why?
| | Mice, Obese | 1 | 2002 | 68 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 2002 | 420 | 0.010 |
Why?
| | Interferon-gamma | 1 | 2002 | 784 | 0.010 |
Why?
| | Killer Cells, Natural | 1 | 2002 | 481 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2002 | 1133 | 0.010 |
Why?
| | Body Weight | 1 | 2002 | 972 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2002 | 1217 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2002 | 5995 | 0.010 |
Why?
| | Mice | 1 | 2002 | 18358 | 0.000 |
Why?
|
|
Lear-Kaul's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|